Search

Your search keyword '"Varela, Juan"' showing total 55 results

Search Constraints

Start Over You searched for: Author "Varela, Juan" Remove constraint Author: "Varela, Juan" Publisher elsevier bv Remove constraint Publisher: elsevier bv
55 results on '"Varela, Juan"'

Search Results

3. POSTER: CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

4. CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

5. Molecular epidemiology of pneumococcal carriage in children from Seville, following implementation of the PCV13 immunization program in Andalusia, Spain

7. Epidemiología molecular de la colonización nasofaríngea neumocócica en niños de Sevilla, tras la implementación del programa de vacunación con VNC13 en Andalucía (España)

14. ThX: a next generation probe for the early detection of amyloid aggregates

15. Documenting the Recovery of Vascular Services in European Centres Following the Initial COVID-19 Pandemic Peak: Results from a Multicentre Collaborative Study

17. Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort Study

19. Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections

20. Outcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) at Nonuniversity Medical Centers (NMCs): Initial Results from the Outreach Study in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

21. Preliminary Results of the First-in-Human Study of Nexi-001, a Multi-Antigen Specific CD8+ T Cell Product, in Acute Myeloid Leukemia (AML) Patients with Relapsed Disease after Allogeneic Hematopoietic Cell Transplantation (Allo-HSCT) Demonstrate Early Signs of Safety, Tolerability and Robust Immune Responses

24. Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation Low-Dose Azacitidine for Prevention of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis

34. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions

35. Designing Electronic Health Record Tools for Efficient CIBMTR Data Management

37. Designing Electronic Health Record Tools for Efficient CIBMTR Data Management

38. Comparison of Outcomes with Two Calcineurin Inhibitor-Based Graft-Versus-Host-Disease Prophylactic Regimens after Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

40. Outcomes after Matched Unrelated Donor and Haploidentical Related Donor Allogeneic Transplantation for Hematological Malignancies: Single Center Experience

41. Specific alteration of NMDA receptor synaptic trafficking by circulating autoantibodies from schizophrenic patients

42. Predictive Value of Absolute Lymphocyte Count at Day 30 Post-Allogeneic Transplantation for Early Mortality Irrespective of GVHD Prophylaxis

46. Author reply

Catalog

Books, media, physical & digital resources